Cleveland-based MetroHealth has extended the contract of President and CEO Christine Alexander-Rager, MD, through Jan. 9, 2029.
The board of trustees unanimously approved the new contract, according to a Dec. 10 health system news release. Dr. Alexander-Rager became acting chief executive in July 2024 and was promoted to president and CEO in October 2024.
Dr. Alexander-Rager has spent 28 years at MetroHealth, including in clinical and leadership roles. Earlier in 2025, she implemented a systemwide plan to address rising costs and an unexpected increase in charity care, which included executive pay cuts, workforce reduction and site closures. While MetroHealth still expects a financial loss for 2025, leadership said the deficit would have been greater without the cost-saving actions outlined in the plan.
Dr. Alexander-Rager succeeded former President and CEO Airica Steed, EdD, RN, who went on medical leave and was later dismissed in August 2024. Dr. Steed has since filed a lawsuit against the system alleging discrimination and unlawful termination, claims MetroHealth has refuted.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
